Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3

Journal of Immunology

Volumn 185, Issue 4, 2010, Pages 2164-2173

  Luo, Shanshan ^a   Hartmann, Andrea ^a   Dahse, Hans Martin ^a   Skerka, Christine ^a   Zipfel, Peter F ^a,b  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR H; COMPLEMENT INHIBITOR; PH REGULATED ANTIGEN 1; UNCLASSIFIED DRUG; FUNGAL PROTEIN; PRA1 PROTEIN, CANDIDA ALBICANS;

ARTICLE; CANDIDA ALBICANS; CELL ADHESION; COMPLEMENT ALTERNATIVE PATHWAY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HUMAN; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN METABOLISM; WESTERN BLOTTING; ANIMAL; CELL LINE; COMPLEMENT ACTIVATION; DRUG ANTAGONISM; DRUG EFFECT; HEMOLYSIS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; RABBIT; SHEEP;

ANIMALS; BLOTTING, WESTERN; CANDIDA ALBICANS; CELL LINE; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT C3A; COMPLEMENT C5A; COMPLEMENT PATHWAY, ALTERNATIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FUNGAL PROTEINS; HEMOLYSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MICROSCOPY, CONFOCAL; PHAGOCYTOSIS; PROTEIN BINDING; RABBITS; SHEEP;

EID: 77956897192     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001011     Document Type: Article

References (62)

1. Sturtevant, J., and R. Calderone. 1997. Candida albicans adhesins: biochemical aspects and virulence. Rev. Iberoam. Micol. 14: 90-97.
2. Pfaller, M. A., L. Boyken, R. J. Hollis, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2005. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. J. Clin. Microbiol. 43: 5425-5427.
3. Tavanti, A., A. D. Davidson, M. J. Fordyce, N. A. Gow, M. C. Maiden, and F. C. Odds. 2005. Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J. Clin. Microbiol. 43: 5601-5613.
4. Richardson, M. D. 2005. Changing patterns and trends in systemic fungal infections. J. Antimicrob. Chemother. 56(Suppl. 1): i5-i11.
5. Zipfel, P. F., and C. Skerka. 2009. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9: 729-740.
6. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344: 1058-1066.
7. Griffiths, M. R., P. Gasque, and J. W. Neal. 2009. The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. J. Neuropathol. Exp. Neurol. 68: 217-226.
8. Seelen, M. A., A. Roos, and M. R. Daha. 2005. Role of complement in innate and autoimmunity. J. Nephrol. 18: 642-653.
9. Walport, M. J. 2001. Complement: second of two parts. N. Engl. J. Med. 344: 1140-1144.
10. Mihlan, M., M. Hebecker, H. M. Dahse, S. Hälbich, M. Huber-Lang, R. Dahse, P. F. Zipfel, and M. Józsi. 2009. Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells. Mol. Immunol. 46: 335-344.
11. Garred, P., C. Honoré, Y. J. Ma, L. Munthe-Fog, and T. Hummelshøj. 2009. MBL2, FCN1, FCN2 and FCN3: the genes behind the initiation of the lectin pathway of complement. Mol. Immunol. 46: 2737-2744.
12. Zipfel, P. F., M. Mihlan, and C. Skerka. 2007. The alternative pathway of complement: a pattern recognition system. Adv. Exp. Med. Biol. 598: 80-92.
13. Walport, M. J., and K. A. Davies. 1996. Complement and immune complexes. Res. Immunol. 147: 103-109.
14. O'Rear, L. D., and G. D. Ross. 2001. Assays for membrane complement receptors. Curr. Protoc. Immunol. Chapter 13: Unit 13.4.
15. van Lookeren Campagne, M., C. Wiesmann, and E. J. Brown. 2007. Macrophage complement receptors and pathogen clearance. Cell. Microbiol. 9: 2095-2102.
16. Lambris, J. D., D. Ricklin, and B. V. Geisbrecht. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6: 132-142.
17. Zipfel, P. F., R. Würzner, and C. Skerka. 2007. Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol. Immunol. 44: 3850-3857.
18. Meri, T., A. Hartmann, D. Lenk, R. Eck, R. Würzner, J. Hellwage, S. Meri, and P. F. Zipfel. 2002. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect. Immun. 70: 5185-5192.
19. Meri, T., A. M. Blom, A. Hartmann, D. Lenk, S. Meri, and P. F. Zipfel. 2004. The hyphal and yeast forms of Candida albicans bind the complement regulator C4bbinding protein. Infect. Immun. 72: 6633-6641.
20. Behnsen, J., A. Hartmann, J. Schmaler, A. Gehrke, A. A. Brakhage, and P. F. Zipfel. 2008. The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system. Infect. Immun. 76: 820-827.
21. Heinen, S., A. Hartmann, N. Lauer, U. Wiehl, H. M. Dahse, S. Schirmer, K. Gropp, T. Enghardt, R. Wallich, S. Hälbich, et al. 2009. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114: 2439-2447.
22. Poltermann, S., A. Kunert, M. von der Heide, R. Eck, A. Hartmann, and P. F. Zipfel. 2007. Gpm1p is a factor H-, FHL-1-, and plasminogen-binding surface protein of Candida albicans. J. Biol. Chem. 282: 37537-37544.
23. Luo, S., S. Poltermann, A. Kunert, S. Rupp, and P. F. Zipfel. 2009. Immune evasion of the human pathogenic yeast Candida albicans: Pra1 is a Factor H, FHL-1 and plasminogen binding surface protein. Mol. Immunol. 47: 541-550.
24. Alitalo, A., T. Meri, L. Rämö, T. S. Jokiranta, T. Heikkilä, I. J. Seppälä, J. Oksi, M. Viljanen, and S. Meri. 2001. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect. Immun. 69: 3685-3691.
25. Kraiczy, P., C. Skerka, M. Kirschfink, V. Brade, and P. F. Zipfel. 2001. Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. Eur. J. Immunol. 31: 1674-1684.
26. Kunert, A., J. Losse, C. Gruszin, M. Hühn, K. Kaendler, S. Mikkat, D. Volke, R. Hoffmann, T. S. Jokiranta, H. Seeberger, et al. 2007. Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J. Immunol. 179: 2979-2988.
27. Ram, S., F. G. Mackinnon, S. Gulati, D. P. McQuillen, U. Vogel, M. Frosch, C. Elkins, H. K. Guttormsen, L. M. Wetzler, M. Oppermann, et al. 1999. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol. Immunol. 36: 915-928.
28. Hallström, T., P. F. Zipfel, A. M. Blom, N. Lauer, A. Forsgren, and K. Riesbeck. 2008. Haemophilus influenzae interacts with the human complement inhibitor factor H. J. Immunol. 181: 537-545.
29. Johnsson, E., K. Berggård, H. Kotarsky, J. Hellwage, P. F. Zipfel, U. Sjöbring, and G. Lindahl. 1998. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. J. Immunol. 161: 4894-4901. (Pubitemid 28492068)
30. Kotarsky, H., J. Hellwage, E. Johnsson, C. Skerka, H. G. Svensson, G. Lindahl, U. Sjöbring, and P. F. Zipfel. 1998. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J. Immunol. 160: 3349-3354.
31. Caswell, C. C., R. Han, K. M. Hovis, P. Ciborowski, D. R. Keene, R. T. Marconi, and S. Lukomski. 2008. The Scl1 protein of M6-type group A Streptococcus binds the human complement regulatory protein, factor H, and inhibits the alternative pathway of complement. Mol. Microbiol. 67: 584-596.
32. Haupt, K., M. Reuter, J. van den Elsen, J. Burman, S. Hälbich, J. Richter, C. Skerka, and P. F. Zipfel. 2008. The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog. 4: e1000250.
33. Meri, T., T. S. Jokiranta, J. Hellwage, A. Bialonski, P. F. Zipfel, and S. Meri. 2002. Onchocerca volvulus microfilariae avoid complement attack by direct binding of factor H. J. Infect. Dis. 185: 1786-1793.
34. Díaz, A., A. Ferreira, and R. B. Sim. 1997. Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J. Immunol. 158: 3779-3786.
35. Stoiber, H., A. Clivio, and M. P. Dierich. 1997. Role of complement in HIV infection. Annu. Rev. Immunol. 15: 649-674.
36. Chung, K. M., M. K. Liszewski, G. Nybakken, A. E. Davis, R. R. Townsend, D. H. Fremont, J. P. Atkinson, and M. S. Diamond. 2006. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Natl. Acad. Sci. USA 103: 19111-19116.
37. Diamond, M. S., E. Mehlhop, T. Oliphant, and M. A. Samuel. 2009. The host immunologic response to West Nile encephalitis virus. Front. Biosci. 14: 3024-3034.
38. Lee, L. Y., M. Höök, D. Haviland, R. A. Wetsel, E. O. Yonter, P. Syribeys, J. Vernachio, and E. L. Brown. 2004. Inhibition of complement activation by a secreted Staphylococcus aureus protein. J. Infect. Dis. 190: 571-579.
39. Hammel, M., G. Sfyroera, S. Pyrpassopoulos, D. Ricklin, K. X. Ramyar, M. Pop, Z. Jin, J. D. Lambris, and B. V. Geisbrecht. 2007. Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. J. Biol. Chem. 282: 30051-30061.
40. Rooijakkers, S. H., M. Ruyken, A. Roos, M. R. Daha, J. S. Presanis, R. B. Sim, W. J. van Wamel, K. P. van Kessel, and J. A. van Strijp. 2005. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6: 920-927.
41. Rooijakkers, S. H., J. Wu, M. Ruyken, R. van Domselaar, K. L. Planken, A. Tzekou, D. Ricklin, J. D. Lambris, B. J. Janssen, J. A. van Strijp, and P. Gros. 2009. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat. Immunol. 10: 721-727.
42. de Haas, C. J., K. E. Veldkamp, A. Peschel, F. Weerkamp, W. J. Van Wamel, E. C. Heezius, M. J. Poppelier, K. P. Van Kessel, and J. A. van Strijp. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiin- flammatory agent. J. Exp. Med. 199: 687-695.
43. Postma, B., M. J. Poppelier, J. C. van Galen, E. R. Prossnitz, J. A. van Strijp, C. J. de Haas, and K. P. van Kessel. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J. Immunol. 172: 6994-7001. (Pubitemid 38669140)
44. Wright, A. J., A. Higginbottom, D. Philippe, A. Upadhyay, S. Bagby, R. C. Read, P. N. Monk, and L. J. Partridge. 2007. Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response. Mol. Immunol. 44: 2507-2517.
45. De Bernardis, F., F. A. Mühlschlegel, A. Cassone, and W. A. Fonzi. 1998. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect. Immun. 66: 3317-3325.
46. Casanova, M., J. L. Lopez-Ribot, C. Monteagudo, A. Llombart-Bosch, R. Sentandreu, and J. P. Martinez. 1992. Identification of a 58-kilodalton cell surface fibrinogen-binding mannoprotein from Candida albicans. Infect. Immun. 60: 4221-4229.
47. Soloviev, D. A., W. A. Fonzi, R. Sentandreu, E. Pluskota, C. B. Forsyth, S. Yadav, and E. F. Plow. 2007. Identification of pH-regulated antigen 1 released from Candida albicans as the major ligand for leukocyte integrin alphaMbeta2. J. Immunol. 178: 2038-2046.
48. Sentandreu, M., M. V. Elorza, R. Sentandreu, and W. A. Fonzi. 1998. Cloning and characterization of PRA1, a gene encoding a novel pH-regulated antigen of Candida albicans. J. Bacteriol. 180: 282-289.
49. Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717-728.
50. Gillum, A. M., E. Y. Tsay, and D. R. Kirsch. 1984. Isolation of the Candida albicans gene for orotidine-59-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198: 179-182.
51. Józsi, M., C. Licht, S. Strobel, S. L. Zipfel, H. Richter, S. Heinen, P. F. Zipfel, and C. Skerka. 2008. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood 111: 1512-1514. (Pubitemid 351213440)
52. Jongerius, I., J. Köhl, M. K. Pandey, M. Ruyken, K. P. van Kessel, J. A. van Strijp, and S. H. Rooijakkers. 2007. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 204: 2461-2471.
53. McRae, J. L., T. G. Duthy, K. M. Griggs, R. J. Ormsby, P. J. Cowan, B. A. Cromer, W. J. McKinstry, M. W. Parker, B. F. Murphy, and D. L. Gordon. 2005. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J. Immunol. 174: 6250-6256.
54. Hammel, M., G. Sfyroera, D. Ricklin, P.Magotti, J. D. Lambris, and B. V. Geisbrecht. 2007. A structural basis for complement inhibition by Staphylococcus aureus. Nat. Immunol. 8: 430-437.
55. Rooijakkers, S. H., W. J. van Wamel, M. Ruyken, K. P. van Kessel, and J. A. van Strijp. 2005. Anti-opsonic properties of staphylokinase. Microbes Infect. 7: 476-484.
56. Zipfel, P. F., T. S. Jokiranta, J. Hellwage, V. Koistinen, and S. Meri. 1999. The factor H protein family. Immunopharmacology 42: 53-60.
57. Distelmaier, K., C. Adlbrecht, J. Jakowitsch, S. Winkler, D. Dunkler, C. Gerner, O. Wagner, I. M. Lang, and M. Kubicek. 2009. Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction. Thromb. Haemost. 102: 564-572.
58. Peng, Q., K. Li, S. H. Sacks, and W. Zhou. 2009. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm. Allergy Drug Targets 8: 236-246.
59. Netea, M. G., C. A. Van Der Graaf, A. G. Vonk, I. Verschueren, J. W. Van Der Meer, and B. J. Kullberg. 2002. The role of Toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 185: 1483-1489.
60. Blasi, E., A. Mucci, R. Neglia, F. Pezzini, B. Colombari, D. Radzioch, A. Cossarizza, E. Lugli, G. Volpini, G. Del Giudice, and S. Peppoloni. 2005. Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans. FEMS Immunol. Med. Microbiol. 44: 69-79.
61. Gantner, B. N., R. M. Simmons, and D. M. Underhill. 2005. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 24: 1277-1286.
62. Choi, W., Y. J. Yoo, M. Kim, D. Shin, H. B. Jeon, and W. Choi. 2003. Identi- fication of proteins highly expressed in the hyphae of Candida albicans by two-dimensional electrophoresis. Yeast 20: 1053-1060.